(Q35679203)
Statements
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction (English)
M Mensah
11 December 2014
1 December 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference